Volume 73, Issue 9, Pages (May 2008)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Hypothesis: an erythropoietin honeymoon phase exists
Steven Fishbane, Jeffrey S. Berns, M.D.  Kidney International 
Volume 54, Issue 2, Pages (August 1998)
Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,
Nutrition and chronic kidney disease
Linear and logistic regression analysis
Iron status and iron supplementation in peritoneal dialysis patients
Volume 85, Issue 5, Pages (May 2014)
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
Red blood cell life span and ‘erythropoietin resistance’
Volume 58, Issue 4, Pages (October 2000)
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Volume 59, Issue 5, Pages (May 2001)
Volume 66, Issue 4, Pages (October 2004)
C-reactive protein and dialysis access
Determinants of phosphorus mobilization during hemodialysis
Naïve and central memory T-cell lymphopenia in end-stage renal disease
Volume 80, Issue 10, Pages (November 2011)
C-reactive protein and dialysis access
Volume 54, Issue 2, Pages (August 1998)
Volume 78, Pages S41-S45 (August 2010)
Yasuhiro Hamada, Masafumi Fukagawa  Kidney International 
Glycemic Management in ESRD and Earlier Stages of CKD
Kamyar Kalantar-Zadeh  Kidney International 
High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury  D.P. Gabriel, J.T. Caramori,
Volume 66, Issue 3, Pages (September 2004)
George A. Kaysen, Burl R. Don
Volume 68, Issue 6, Pages (December 2005)
Progression of diabetic nephropathy
Comorbidity and confounding in end-stage renal disease
Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought  Nicolas Rognant, Maurice Laville  Kidney.
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Nutrition and chronic kidney disease
Darbepoetin alfa: A new therapeutic agent for renal anemia
Renal risk scores: Progress and prospects
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Nephrology Crosswords: Hemodialysis
The calcium–phosphorus in guidelines for CKD-MBD
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure  A. Parikova, W. Smit, D.G. Struijk,
Volume 67, Pages S48-S51 (January 2005)
Blood pressure targets in hemodialysis patients
Volume 78, Issue 2, Pages (July 2010)
Volume 76, Issue 3, Pages (August 2009)
Extracorporeal therapy in sepsis: are we there yet?
Abdulla K. Salahudeen, Erwin H. Fleischmann, John D. Bower 
Alternate-day dialysis may be needed for hemodialysis patients
Nephrology Crossword: Peritoneal Dialysis
Alfonso M. Cueto-Manzano, Ricardo Correa-Rotter  Kidney International 
Volume 55, Issue 5, Pages (May 1999)
Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,
Current status of maintenance hemodialysis in Beijing, China
K. Kalantar-Zadeh, J. D. Kopple, N. Kamranpour, A. M. Fogelman, M
Volume 64, Issue 3, Pages (September 2003)
Nosratola D. Vaziri, M.D., Kaihui Liang  Kidney International 
Volume 80, Issue 10, Pages (November 2011)
Volume 74, Issue 9, Pages (November 2008)
Volume 80, Issue 10, Pages (November 2011)
Volume 60, Issue 6, Pages (December 2001)
Volume 57, Issue 2, Pages (October 2000)
Volume 75, Issue 9, Pages (May 2009)
Volume 75, Issue 7, Pages (April 2009)
Membranous nephropathy: recent travels and new roads ahead
Volume 55, Issue 3, Pages (March 1999)
Lipoprotein abnormalities in diabetic nephropathy
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients  Bradley A. Ford, Charles S. Eby,
Characteristics of sudden death in hemodialysis patients
Presentation transcript:

Volume 73, Issue 9, Pages 1062-1068 (May 2008) Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis  T.P. Peacock, Z.K. Shihabi, A.J. Bleyer, E.L. Dolbare, J.R. Byers, M.A. Knovich, J. Calles-Escandon, G.B. Russell, B.I. Freedman  Kidney International  Volume 73, Issue 9, Pages 1062-1068 (May 2008) DOI: 10.1038/ki.2008.25 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Correlation between HbA1c and glycated albumin, by ESRD status. Relationship between % HbA1c and % GA in diabetic subjects with ESRD (upper panel) and without nephropathy (lower panel). Slopes of the lines differ between groups (0.163 for diabetes mellitus (DM)-ESRD, 0.190 for DM nonnephropathy patients, P=0.0001). Reference lines represent normal values. Kidney International 2008 73, 1062-1068DOI: (10.1038/ki.2008.25) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Correlation between HbA1c and glycated albumin assays with random serum glucose concentrations, by ESRD status. Upper panel: HbA1c vs mean serum glucose concentration; when testing the regression lines there is a significant difference between diabetic hemodialysis patients and those without nephropathy, P<0.0001. Lower panel: % GA vs mean serum glucose concentration; testing the regression lines there is no significant difference between the groups, P=0.19. Circles depict subjects without nephropathy; boxes depict dialysis patients. Kidney International 2008 73, 1062-1068DOI: (10.1038/ki.2008.25) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Impact of hemoglobin concentration and EPO dose on HbA1c in diabetic ESRD. Relationship between HbA1c and weekly erythropoietin dose (upper panel); and hemoglobin concentration (lower panel) in diabetic subjects on hemodialysis. Kidney International 2008 73, 1062-1068DOI: (10.1038/ki.2008.25) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 Impact of hemoglobin concentration, serum albumin and EPO dose on glycated albumin in diabetic ESRD. Relationship between % GA and serum albumin concentration (upper panel); weekly erythropoietin dose (middle panel); and hemoglobin concentration (lower panel) in diabetic subjects on hemodialysis. Kidney International 2008 73, 1062-1068DOI: (10.1038/ki.2008.25) Copyright © 2008 International Society of Nephrology Terms and Conditions